Ignite Creation Date:
2024-05-05 @ 5:15 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00412217
Status:
TERMINATED
Last Update Posted:
2016-11-25
First Post:
2006-12-15
Brief Title:
A Study of Erlotinib Tarceva in Participants With Resected Head and Neck Squamous Cell Cancer
Sponsor:
Hoffmann-La Roche
Organization:
Hoffmann-La Roche
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-11
Start Date Type:
None
Primary Completion Date:
2009-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-12
Completion Date Type:
ACTUAL
First Submit Date:
2006-12-15
First Submit QC Date:
December 15 2006
Study First Post Date:
2006-12-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2016-09-26
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-10-11
Last Update Post Date:
2016-11-25
Last Update Post Date Type:
ESTIMATED